Perry J - Search Results

1

The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers.

Noel EE, Yeste-Velasco M, Mao X, Perry J, Kudahetti SC, Li NF, Sharp S, Chaplin T, Xue L, McIntyre A, Shan L, Powles T, Oliver RT, Young BD, Shipley J, Berney DM, Joel SP, Lu YJ. Noel EE, et al. Among authors: perry j. Am J Pathol. 2010 Jun;176(6):2607-15. doi: 10.2353/ajpath.2010.090780. Epub 2010 Apr 15. Am J Pathol. 2010. PMID: 20395447 Free PMC article.

2

Identification of genomic changes associated with cisplatin resistance in testicular germ cell tumor cell lines.

Noel EE, Perry J, Chaplin T, Mao X, Cazier JB, Joel SP, Oliver RT, Young BD, Lu YJ. Noel EE, et al. Among authors: perry j. Genes Chromosomes Cancer. 2008 Jul;47(7):604-13. doi: 10.1002/gcc.20564. Genes Chromosomes Cancer. 2008. PMID: 18384131

3

The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines.

Perry J, Powles T, Shamash J, Veerupillai A, McGrowder E, Noel E, Lu YJ, Oliver T, Joel S. Perry J, et al. Cancer Chemother Pharmacol. 2009 Oct;64(5):925-33. doi: 10.1007/s00280-009-0944-6. Epub 2009 Mar 5. Cancer Chemother Pharmacol. 2009. PMID: 19263053

4

A synergistic interaction between lapatinib and chemotherapy agents in a panel of cell lines is due to the inhibition of the efflux pump BCRP.

Perry J, Ghazaly E, Kitromilidou C, McGrowder EH, Joel S, Powles T. Perry J, et al. Mol Cancer Ther. 2010 Dec;9(12):3322-9. doi: 10.1158/1535-7163.MCT-10-0197. Epub 2010 Oct 1. Mol Cancer Ther. 2010. PMID: 20889729

5

Development and validation of an ultra-high performance LC-MS/MS assay for intracellular SN-38 in human solid tumour cell lines: comparison with a validated HPLC-fluorescence method.

Ghazaly E, Perry J, Kitromilidou C, Powles T, Joel S. Ghazaly E, et al. Among authors: perry j. J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Oct 15;969:213-8. doi: 10.1016/j.jchromb.2014.08.024. Epub 2014 Aug 27. J Chromatogr B Analyt Technol Biomed Life Sci. 2014. PMID: 25195021

6

The histone deacetylase inhibitor UCL67022 has potent activity in multiple myeloma and non-Hodgkin lymphoma pre-clinical models.

Maharaj L, Marson CM, Middleton BJ, Rioja AS, Perry J, Oakervee H, Cavenagh J, Joel SP, Popat R. Maharaj L, et al. Among authors: perry j. Br J Haematol. 2013 Oct;163(1):135-9. doi: 10.1111/bjh.12456. Epub 2013 Jul 9. Br J Haematol. 2013. PMID: 23834265 Free article. No abstract available.

7

Phase I and pharmacokinetic study of intravenous irinotecan plus oral ciclosporin in patients with fuorouracil-refractory metastatic colon cancer.

Chester JD, Joel SP, Cheeseman SL, Hall GD, Braun MS, Perry J, Davis T, Button CJ, Seymour MT. Chester JD, et al. Among authors: perry j. J Clin Oncol. 2003 Mar 15;21(6):1125-32. doi: 10.1200/JCO.2003.08.049. J Clin Oncol. 2003. PMID: 12637480 Clinical Trial.

8

Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric Population.

Maglalang PD, Sinha J, Zimmerman K, McCann S, Edginton A, Hornik CP, Hornik CD, Muller WJ, Al-Uzri A, Meyer M, Chen JY, Anand R, Perrin EM, Gonzalez D; Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee. Maglalang PD, et al. Clin Pharmacokinet. 2024 May 30. doi: 10.1007/s40262-024-01367-2. Online ahead of print. Clin Pharmacokinet. 2024. PMID: 38814425

9

Magnetic Resonance Imaging of the Velopharynx: Clinical Findings in Patients with Velopharyngeal Insufficiency.

Sitzman TJ, Williams JL, Singh DJ, Temkit M, Snodgrass TD, Perry JL. Sitzman TJ, et al. Among authors: perry jl. Plast Reconstr Surg. 2024 Jun 1;153(6):1155e-1168e. doi: 10.1097/PRS.0000000000010798. Epub 2023 Jun 6. Plast Reconstr Surg. 2024. PMID: 38810162

10

Metabolome-wide Mendelian randomization for age at menarche and age at natural menopause.

Yazdanpanah M, Yazdanpanah N, Gamache I, Ong K, Perry JRB, Manousaki D. Yazdanpanah M, et al. Among authors: perry jrb. Genome Med. 2024 May 28;16(1):69. doi: 10.1186/s13073-024-01322-7. Genome Med. 2024. PMID: 38802955 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,887 results

Search Page